Cureus

Tirzepatide's effects on obstructive sleep apnea

Updated

Abstract

Tirzepatide has demonstrated significant glycemic control and weight loss.

  • Obstructive sleep apnea is often linked to obesity and negatively impacts health and quality of life.
  • Weight loss is a primary treatment approach for managing obstructive sleep apnea.
  • Tirzepatide acts as a dual agonist for two hormones, potentially influencing metabolic processes.
  • Current literature explores tirzepatide's effects on obstructive sleep apnea and its mechanism of action.
  • Complications and off-label uses of tirzepatide are also discussed in the context of metabolic conditions.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free